Medicine-induced Cardiac Hemodialysis on COVID-19
NCT05711810 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 1
Last updated 2023-02-03
Summary
The clinical trial studies the human pathogen of SARS-CoV-2, with a specificity in the circulating Spike 2 protein in the human system. The clinical trial hypothesizes that SARS-CoV-2 human pathogen arises from immune attacks, underlying the severe physiological symptoms that can be lethal. It further hypothesizes that the vaccines do not deal with the Spike 2 protein that causes the immune attacks.
Conditions
- Severe Acute Respiratory Syndrome-related Coronavirus
- Renal Dialysis
- Vaccines
- Myocarditis Allergic
- Infection Viral
Interventions
- DRUG
-
Nifedipine 30 MG
Due to initial availability of drugs and the intensities of the patient's symptoms, Nifedipine was used for initial intervention in preventing acute myocarditis from happening.
- DIAGNOSTIC_TEST
-
Kangzhu BPCB0A-3A
The diagnostic test has been used to confirm objective parameters to guide the intervention drug dosages and accessing the risks in sudden death and long term adverse effects.
- BEHAVIORAL
-
Low Mobility
The behavioral intervention aimed at reducing the risks of sudden and strong blood flows in the patient's system.
- DRUG
-
Enalapril Maleate 10Mg Tab
The intervention aims to reduce the vein flows in Diastolic Blood Pressure, and the risks in blood clot formation and internal vein scratch bleeding.
- DRUG
-
Lansoprazole 30Mg Ec Cap
The intervention aims to server the allergy-inducing proteins to induce renal hemodialysis.
- DRUG
-
Metoprolol Succinate
Metoprolol Succinate is used to control the cardiac artery flow amounts and stabilize the patient's heart rate.
- DIETARY_SUPPLEMENT
-
Coenzyme Q10
200 mg per day is used for supplement with the cardiac interventions.
- DIETARY_SUPPLEMENT
-
d-alpha tocopherol acetate
The 268 mg twice per day dietary healthcare is the patient's usual daily use.
- DIETARY_SUPPLEMENT
-
Omega-3
The 900 mg twice per day dietary healthcare is the patient's usual daily use.
- DRUG
-
Duloxetine Hydrochloride 20 MG Oral Capsule, Delayed Release
Duloxetine hydrochloride is used for the patient's neurodiverse conditions.
- DRUG
-
Superoxide Dismutase
Superoxide Dismutase is used to substitute the missing of antiviral drugs.
Sponsors & Collaborators
-
Yang I. Pachankis
lead INDIV
Study Design
- Allocation
- NA
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-01-02
- Primary Completion
- 2023-01-10
- Completion
- 2023-01-12
- FDA Drug
- Yes
Countries
- China
Study Locations
More Related Trials
-
Safety Evaluation of Linear and Macrocyclic Gadolinium Based Contrast Agents for Patients With Mild to Moderate Renal Insufficiency Undergoing Enhanced Magnetic Resonance Imaging
NCT04776187 ·Status: UNKNOWN ·Phase: PHASE4
-
Study to Evaluate the Pharmacokinetics, Safety, and Pharmacodynamics of INCB054707 in Participants With Normal and Impaired Renal Function and Participants on Hemodialysis
NCT05624723 ·Status: COMPLETED ·Phase: PHASE1
-
COVID-19 Vaccine Boosters in Patients With CKD
NCT05022329 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Effect of SNF472 on Progression of Cardiovascular Calcification in End-Stage-Renal-Disease (ESRD) Patients on Hemodialysis (HD)
NCT02966028 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase I Clinical Study of Recombinant Humanized Anti-CD20(B-lymphocyte Antigen CD20) Monoclonal Antibody Subcutaneous Injection in the Treatment of Primary Membranous Nephropathy
NCT05668403 ·Status: RECRUITING ·Phase: PHASE1
-
Senescence in Chronic Kidney Disease
NCT02848131 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2
-
Study of the Efficacy and Safety of BCD-131 and Mircera® in the Treatment of Anemia in Patients With Chronic Kidney Disease on Dialysis
NCT07119372 ·Status: RECRUITING ·Phase: PHASE3
-
A Study to Learn About How Well BAY3283142 Works and Its Safety in Participants With Chronic Kidney Disease
NCT06522997 ·Status: COMPLETED ·Phase: PHASE2
-
Dose Ranging Study of Dialysate Containing Soluble Iron to Treat Subjects With End Stage Renal Disease (ESRD) Receiving Chronic Hemodialysis
NCT00548249 ·Status: COMPLETED ·Phase: PHASE2
-
Pomegranate and Hemodialysis Pilot Trial
NCT01562340 ·Status: COMPLETED ·Phase: NA
-
Efficacy, Safety and Tolerability of Balcinrenone/Dapagliflozin Compared to Dapagliflozin in Adults With Chronic Kidney Disease
NCT06350123 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Pharmacokinetics of MK-2060 in Older Participants With End-Stage Renal Disease on Hemodialysis (MK-2060-004)
NCT03873038 ·Status: COMPLETED ·Phase: PHASE1
-
A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(5)
NCT05749861 ·Status: COMPLETED ·Phase: PHASE1
-
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis
NCT05485961 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
High-protein Oral Supplement With Liposomal Curcumin in Adults Undergoing Hemodialysis.
NCT06381076 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Pharmacokinetics and Safety of LY3537031 in Participants With Normal Renal Function and Participants With Renal Impairment
NCT07165015 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Pharmacokinetics of ANG-3777 in Hemodialysis Subjects
NCT04958187 ·Status: UNKNOWN ·Phase: PHASE1
-
A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With Reduced Kidney Function
NCT07315360 ·Status: RECRUITING ·Phase: PHASE1
-
Study to Investigate the Effects of AZD6140 in Patients With Renal Impairment and in Healthy Volunteers
NCT00733265 ·Status: COMPLETED ·Phase: PHASE1
-
A Trial of Bardoxolone Methyl in Patients With CKD at Risk of Rapid Progression (MERLIN)
NCT04702997 ·Status: COMPLETED ·Phase: PHASE2
-
Study of MCI-196 in Chronic Kidney Disease Stage V Subjects on Dialysis With Hyperphosphatemia
NCT00772382 ·Status: COMPLETED ·Phase: PHASE3
-
End-stage Renal Disease (ESRD) Pilot Study
NCT03787368 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety Study of MCI-196 Versus Simvastatin for Dyslipidaemia in Chronic Kidney Disease (CKD) Subjects on Dialysis
NCT00858637 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Trial to Evaluate the Tolerability and the Pharmacokinetics of CKD-348
NCT05549401 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluate the Efficacy and Safety of ABP-671 in Subjects With Chronic Kidney Disease and Hyperuricaemia
NCT07323095 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2